Prognostic significance of pleural fluid data in patients with malignant effusion.
about
Interventions for the management of malignant pleural effusions: a network meta-analysisInterventions for the management of malignant pleural effusionsPleural LDH as a prognostic marker in adenocarcinoma lung with malignant pleural effusionDemonstration of anti-tumor activity of oncolytic measles virus strains in a malignant pleural effusion breast cancer model.Diagnostic and prognostic value of soluble syndecan-1 in pleural malignancies.Cell-free microRNA expression profiles in malignant effusion associated with patient survival in non-small cell lung cancer.Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score.Important prognostic factors for survival in patients with malignant pleural effusion.Clinico- pathological profile and course of malignant pleural effusion in a tertiary care teaching hospital in western U.P. with special reference to lung cancerEGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway.Clinicopathological profile and course of malignant pleural effusion in a tertiary care teaching hospital in western Uttar Pradesh with special reference to lung cancerPrognostic value of aberrant hypermethylation in pleural effusion of lung adenocarcinoma.A pilot study-is there a role for mitoxantrone pleurodesis in the management of pleural effusion due to lung cancer?Predictors of survival in patients who underwent video-assisted thoracic surgery talc pleurodesis for malignant pleural effusion.Diagnosis and management options in malignant pleural effusions.Translational advances in pleural malignancies.Malignant pleural effusion: medical approaches for diagnosis and management.Prognostic impact of a new score using neutrophil-to-lymphocyte ratios in the serum and malignant pleural effusion in lung cancer patients.Prognostic Factors of 30-day Survival of Patients with Malignant Pleural Effusion.Clinical value of jointly detection serum lactate dehydrogenase/pleural fluid adenosine deaminase and pleural fluid carcinoembryonic antigen in the identification of malignant pleural effusion.Tumor type influences the effectiveness of pleurodesis in malignant effusions.Prognostic factors in patients with malignant pleural effusion: Is it possible to predict mortality in patients with good performance status?Prognostic Factors of 30-Day Mortality After Palliative Procedures in Patients with Malignant Pleural Effusion.Loss of steroid hormone receptors is common in malignant pleural and peritoneal effusions of breast cancer patients treated with endocrine therapy.Vascular endothelial growth factor and protein level in pleural effusion for differentiating malignant from benign pleural effusion.Expression of calretinin by breast carcinoma and the potential for misdiagnosis of mesothelioma.Diagnosis and management of malignant pleural effusions: state of the art in 2017.Prognostic Significance of Blood, Serum, and Ascites Parameters in Patients with Malignant Peritoneal Mesothelioma or Peritoneal Carcinomatosis.
P2860
Q24185776-FA283547-145F-4176-9D10-140EA6F9AB8AQ24203029-6CF72AF2-DDEF-49B0-8B15-452110C25000Q28830889-018BC5CA-9C96-4EC4-AF9A-5FE0A7F137F0Q30496489-93729863-2357-439E-8D5D-D25E4862252FQ34039967-115C4030-1DCB-4FC0-BCA9-254632AA9CFCQ34399019-EF4EB195-6633-4F14-85D2-391970BC63EEQ34608340-E7F550EC-E99D-468F-936C-33C38D5732A0Q35232954-FC610066-F994-4BDD-A6B1-544581904FA8Q35851339-6F3A7A54-3820-49C8-BCCE-104E4720CEC3Q36026188-3E339ECD-3F76-4D25-8401-3030CAC56D98Q36330762-203F7B91-D5EE-4AA5-851A-24297EE98168Q36524222-E8973414-8562-4CD9-B597-A3CA3D025292Q36924922-5004F486-ED64-4F6A-9AED-ACF5DEFC2443Q37060372-9ECE02CB-79BE-4EE4-93CC-A7AABB28915EQ37701196-D9B51DAC-57D3-4A7F-94AB-3474CAF5601DQ37806309-E9B6B144-3F29-42A8-A4DC-4A9A3B95AB6BQ38219643-8860FE44-A66E-46FE-87EE-C430B3B62440Q38399545-F7C8891E-64F0-4B32-A09D-9451CD0E11D7Q38615107-FFE45686-AF19-4988-A8A0-0F466C15AD7AQ39099296-FD4726CA-CB76-4CB1-A0BF-8529BA2F8BAEQ39270950-87351849-CEE9-4AB3-BF4E-0E4BEB6C889EQ40987505-046B011A-73C0-45F9-87DC-4442C621669CQ41251928-3865896A-71AE-4FAC-AB76-D44C818AA9A4Q41547969-714C87A3-808E-48C6-B5D7-44552C21D9B8Q41619101-132BB186-7227-4DF5-9B0E-F451AD3CCD77Q42497489-CB05CA4D-E831-44E1-B121-D0E920579700Q46481901-522602EE-9534-4E1F-9FB7-7DA1BB14A740Q54936098-3B64493A-9EBA-4EBA-A8D2-5D4812371BEE
P2860
Prognostic significance of pleural fluid data in patients with malignant effusion.
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Prognostic significance of pleural fluid data in patients with malignant effusion.
@ast
Prognostic significance of pleural fluid data in patients with malignant effusion.
@en
type
label
Prognostic significance of pleural fluid data in patients with malignant effusion.
@ast
Prognostic significance of pleural fluid data in patients with malignant effusion.
@en
prefLabel
Prognostic significance of pleural fluid data in patients with malignant effusion.
@ast
Prognostic significance of pleural fluid data in patients with malignant effusion.
@en
P2093
P50
P1476
Prognostic significance of pleural fluid data in patients with malignant effusion
@en
P2093
Antonio Martín
Francisco Rodríguez-Panadero
José M Porcel
P304
P356
10.1016/J.EJIM.2007.09.014
P577
2007-11-08T00:00:00Z